|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
4.240 -0.300 (-6.608%) | 2026/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2025/03 RMB(K¥) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | |
| Turnover | 34,255,122 | 11.951% | 30,598,292 | 27,026,555 | 26,763,016 | 20,577,616 |
| Cost of Sales | (26,045,005) | 12.427% | (23,166,201) | (21,131,234) | (21,061,682) | (16,469,623) |
| Gross Profit | 8,210,117 | 10.468% | 7,432,091 | 5,895,321 | 5,701,334 | 4,107,993 |
| 2026/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2025/03 RMB(K¥) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 2,166 | -- | (64,663) | (5,926) | 11,381 | (45,620) | |
| Profit / (Loss) before Taxation | 2,274,220 | 45.786% | 1,559,968 | 939,399 | 550,994 | (252,514) | |
| Taxation | (337,878) | 164.062% | (127,954) | (56,263) | (14,485) | (13,427) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (180) | -- | 413 | 341 | (856) | 386 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,936,162 | 35.167% | 1,432,427 | 883,477 | 535,653 | (265,555) | |
| 2026/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2025/03 RMB(K¥) | 2024/03 RMB(K¥) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | |
| Net Finance Costs / (Income) | (462,028) | -0.046% | (462,240) | (472,061) | (325,755) | (206,023) |
| Depreciation & Amortisation | 53,241 | -7.576% | 57,605 | 53,682 | 63,719 | 60,576 |
| Directors' Emoluments | -- | -- | 40,465 | 32,547 | 22,243 | 27,436 |
| 2026/03 - Final | %Chg (Compare to Final) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/03 - Final | %Chg (Compare to Final) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| EPS (cts) | 12.020 | 34.905% | 8.910 | 6.290 | 3.970 | -1.970 |
| DPS (cts) | 19.470 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 161.980% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.087 | 0.077 | 0.019 | 0.031 |
| NBV per share ($) | 1.104 | -- | 1.014 | 0.904 | 1.122 | 1.043 |
| Remarks: | Real time quote last updated: 15/05/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,936,162 |
| %Change | 35.167% |
| EPS / (LPS) | RMB 0.120 |
| NBV Per Share (¥) | RMB 1.104 |